• Info
  • Significant Ownership

Significant Ownership of Lind Global Fund III LP

Signature - Title
By: Lind Global Partners III LLC, its General Partner, By: /s/ Jeff Easton - Jeff Easton, Managing Member
Location
New York, NY
Summary
This page shows a list of all the recent SCHEDULE 13D/G filings made by Lind Global Fund III LP.

Follow Filing Activity

Follow Lind Global Fund III LP and return when a new Schedule 13D/G filing appears.

This tracks SEC filing changes for this page using existing product update flows.

Sign up to follow filing activity

Sponsored

Significant Ownership of Lind Global Fund III LP

Sym Company Class Ownership Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
IVDA Iveda Solutions, Inc. Common Stock, par value $0.00001 per share 10% $1,054,617 1,158,920 Lind Global Fund III LP 11 Feb 2026
ENVB Enveric Biosciences, Inc. Common Stock, $0.01 par value 10% $552,346 141,265 Lind Global Fund III LP 28 Jan 2026
IBG Innovation Beverage Group Ltd Ordinary Shares, no par value per share 10% $130,725 181,562 Lind Global Fund III LP 16 Mar 2026
DFSC DEFSEC Technologies Inc. Common Shares, no par value 9.9% $683,329 197,494 Lind Global Fund III LP 18 Dec 2025
BNGO Bionano Genomics, Inc. Common Stock, $0.0001 par value per share 9.4% $1,669,500 +$851,703 1,050,000 +104% Lind Global Fund III LP 31 Dec 2025
SLXN Silexion Therapeutics Corp Ordinary shares, par value $0.0135 per share 6.4% $187,000 -$10,164 212,500 -5.2% Lind Global Fund III LP 30 Sep 2025

Schedules 13D/G Reported by Lind Global Fund III LP:

Sym Target Class Ownership Change Current Shares Change Value Reporting name Form Report Period Filing Date
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Sponsored